drugset / Trial / NCT02911350
Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the combination therapy of Hormone, Paclitaxel and Radiation therapy are effective in treatment of locally advanced prostate cancer
Timeline
- Start
- 2000-05
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bicalutamide | Other / unclassified | — | — |
| Subject | Goserelin | Other / unclassified | — | — |
| Subject | Leuprolide | Other / unclassified | — | — |
| Subject | Paclitaxel | Small molecule | 30 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 35 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 40 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 45 mg/m2 | Intravenous |
| Subject | flutamide | Small molecule | — | — |